• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: September 18-22


ICYMI, this week we had articles about periorbital rejuvenation, treating all skin tones, improving basal cell carcinoma management, and more.

Aircrews Face Increased Risk of Developing Skin Cancer

Frequent fliers, including pilots and cabin crew, are exposed to greater levels of UV and cosmic ionizing radiation than the general population, leading to higher incidence of skin cancers.

Periorbital Rejuvenation: Comprehensive Assessment and Product Choice Are Key to Results

With a wide range of aesthetic options available, clinicians can create a personalized approach to addressing age-related changes around the eye to give patients the natural-looking results they desire.

POLL: Do You Routinely Inquire About Your Patients' Skin Care Routines and Habits?

This Skin Care Awareness Month, we want to hear more about your experiences with discussing skin care habits with your patients. Click to answer this week's poll.

Psychiatric Comorbidities Present in 1 in 4 Patients With HS

Affective, anxiety, and neurotic disorders were among the most common in a recent study.

ResVita Bio Awarded NIAID Grant for Atopic Dermatitis Research

The Small Business Innovation Research grant enables ResVita Bio to develop RVB-101 for treatment of severe atopic dermatitis.

Nemolizumab Improved Clinical Severity of Prurigo Nodularis

A study found that 193 proteins were differentially expressed after nemolizumab treatment.

Addressing Cultural Disconnect in Patients With Vitiligo

Clinicians can use culturally competent care to ease patients’ concerns with identity and better understand the emotional toll of the condition.

Treating All Skin Tones

Mona Shahriari, MD, introduces "Psoriasis Gaps in Care," a special section of the Dermatology Times September print issue dedicated to skin of color research in psoriasis.

Roflumilast Cream Meets Primary Endpoint for Treatment of Atopic Dermatitis

Roflumilast cream .05% for mild to moderate atopic dermatitis in children also met secondary end points.

Dupilumab Steadily Reduces IgE Levels of Patients With Atopic Dermatitis

Investigators found a steady reduction of IgE levels in patients regardless of dupilumab dosing interval.

Dermoscopy Aids in Diagnosing Psoriasis Vulgaris and Nail Psoriasis

Specific dermoscopic features help determine a diagnosis and the severity of disease.

Antimicrobial Peptides Show Promise in Management of Atopic Dermatitis

Natural and synthetic antimicrobial peptides can penetrate deeper skin layers.

Pointers With Portela: What to Know About Ozempic

In this week’s Pointers With Portela, the 208SkinDoc discusses 5 key takeaways about Ozempic, including adverse effects and hidden risks.

Accurately Recognizing and Diagnosing Psoriasis in Patients With Skin of Color

There may be delays in diagnosis and treatment of psoriasis in patients with darker skin tones due to the clinical presentation variations and less visible erythema.

Frontline Forum Part 3: Improving Basal Cell Carcinoma Management

In part 3 of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, discuss non-surgical treatment options for the management of BCC, dose adjustments for systemic treatments, combining hedgehog pathway inhibitors with immunotherapy, and more.

Navigating Topical Steroid Withdrawal and Extreme Adverse Reactions to Corticosteroids

Peter Lio, MD, offers perspectives on topical steroid withdrawal, also known as red skin syndrome or topical steroid addiction.

Journal Digest: September 20

This week’s collection of the latest dermatologic studies covers dermatologic care for patients with disorders of sex development, stem cell transplantation for vitiligo, switching biologic therapies for psoriasis, and combination therapy for hidradenitis suppurativa.

Considerations for Preventing and Addressing Alopecia in Patients With Religious Headwear

Prior research has demonstrated an association between religious headwear and traction alopecia.

FDA Delays UCB’s Bimekizumab Approval

FDA action is no longer expected in Q3 of 2023.

Hyaluronic Acid-Based Fillers Effective in Treating Signs of Aging

Multiple microinjections significantly improved signs of aging up to 12 weeks after initial injection.

Hidradenitis Suppurativa May Lead to Skin Changes, Peripheral Neuropathy

Changes to skin and nerve endings as a result of HS may contribute to peripheral neuropathy.

Previewing ​Dermatology Times​ Editorial Advisory Board Member Sessions: Science of Skincare Summit 2023

Among the many sessions to be held at the 2023 Science of Skincare Summit in Austin, Texas, several Dermatology Times® Editorial Advisory Board members are preparing to share their knowledge and insights.

Patients With Acne Vulgaris Did Not Display Significant Resistance Differences Versus 7 Antibiotics

While some resistance was noted against azithromycin, clindamycin, and erythromycin, they were not statistically significant.

The Dermatologists' Role in Health Care & Legislative Advocacy ft. Marty Makary, MD, MPH, FACS

Public health/public policy researcher and New York Times best-selling author Marty Makary, MD, MPH, FACS, discusses the role of physician-led legislative advocacy in health care and dermatology.

Research Finds Dermatology Visits for Acne Higher in Adult Female Patients

Yale School of Medicine researchers found tetracycline-class antibiotics were the most prescribed acne treatment for adult female patients between 2002 and 2016.

CALL FOR INSIGHTS: Seeking Challenging Cases, Lingering Questions, & More for AD Awareness Month

Share your insights ahead of October's National Eczema Awareness Month by emailing our team at DTEditor@mmhgroup.com.

Microwave Therapy Successful for Treating Warts in Children

Full clearance of recalcitrant warts was achieved in 68.6% of patients.

Addressing Misconceptions, Concerns Around Biosimilar Use

Research has shown that biosimilars are highly similar to their originator product in terms of safety and efficacy.

Native American and Indigenous Communities Face Dermatologic Barriers to Care, Disparities, and More

Today is National Native American Day. Dermatology Times is reviewing the unique dermatologic concerns and disparities faced by members of the Native and Indigenous communities.

Frontline Forum Part 4: Improving Basal Cell Carcinoma Management

In the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.

Combination Treatments in HS Require Further Review

A systematic review found that generally, combination therapy has evidence supportive of its efficacy in hidradenitis suppurativa.

Colloidal Oatmeal Effective in Improving Atopic Dermatitis in Black Children

Efficacy of 1% colloidal oatmeal cream was similar to prescription barrier cream in treating mild to moderate atopic dermatitis.

CeraVe Partners With George Washington University to Expand Residency Training Program

Eligible candidates should apply by October 15, 2023, and one candidate will match in March 2024.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.